About Lonza 

Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through our Pharma Biotech & Nutrition segment and our Specialty Ingredients segment businesses, we harness science and technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat or even cure severe diseases.

Patients and consumers benefit from our ability to transfer our pharma know-how to the healthcare, hygiene and fast-moving consumer goods environment and to the preservation and protection of the world where we live.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 15,500 full-time employees worldwide at the end of 2018. The company generated sales of CHF 5.5 billion at the end 2018 with a CORE EBITDA of CHF 1.5 billion.



Marc Funk
Chief Executive Officer
Sven Abend Chief Operating Officer
Stefan Stoffel Chief Operating Officer
Rodolfo Savitzky Chief Financial Officer

Major Sites

Alpharetta, GA (USA)
Visp, Switzerland
Bend, OR (USA)
Nansha, China
Blackley (UK)
Ploërmel, France
Bornem, Belgium
Portsmouth, NH (USA)
Delhi, India Puebla, Mexico
Greenwood, SC (USA) Sagamihara, Japan
Kouřim, Czech Republic              Salto, Brazil
Porriño, Spain Suzhou, China
Rochester, NY (USA) Walkersville, MD (USA)
Slough, United Kingdom Williamsport, PA (USA)
Tuas, Singapore  
Tuas, Singapore
Tuas, Singapore
Tuas, Singapore